[The protective and noxious effect of catecholamines during postinsulin hypoglycemia in rats].
D000313:Adrenal Medulla / Q000502:physiology / Q000601:surgery; D000818:Animals; D002319:Cardiovascular System / Q000187:drug effects; D002395:Catecholamines / Q000627:therapeutic use*; D004878:Ergotamine / Q000627:therapeutic use; D005215:Fasting; D005260:Female; D007003:Hypoglycemia / Q000139:chemically induced / Q000517:prevention & control*; D007328:Insulin; D008297:Male; D010643:Phenoxybenzamine / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D011654:Pulmonary Edema / Q000517:prevention & control; D051381:Rats; D013997:Time Factors
D002395:Catecholamines; D007328:Insulin; D010643:Phenoxybenzamine; D004878:Ergotamine; D010646:Phentolamine
L'effet protecteur et nocif des catécholamines pendant l'hypoglycémie postinsulinique chez les rats.